Аңдатпа
Rapid identification of patients at risk of contrast-induced acute kidney injury (AKI) is essential in acute settings such as myocardial infarction (MI) and stroke. Point-of-care (POC) creatinine testing offers immediate kidney function results, but its reliability compared with standard laboratory measurements remains uncertain. This study evaluated the agreement between laboratory and POC creatinine–based risk stratification and their association with subsequent AKI after contrast angiography.